Evidence map›Paper›PMID 22188984›Full record

ArticleFertility and sterility2012

Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro.

Samir Alexandre Boukaidi, Anne Cooley, Ashley Hardy, Laura Matthews, Stanislav Zelivianski, Jacqueline S Jeruss

Open access · greenAbstract read
In one paragraph

Article in Fertility and sterility, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.Journal of the National Cancer Institute · 2015
    Article
  3. Article
  4. Fertility preservation in breast cancer patients.Breast cancer (Tokyo, Japan) · 2014
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Samir Alexandre BoukaidiDepartment of Obstetrics, Gynecology and Reproductive Medicine, L'Archet Hospital, Nice, France.
Anne Cooley
Ashley Hardy
Laura Matthews
Stanislav Zelivianski
Jacqueline S Jeruss
Northwestern University · USHôpital l'Archet · FRIndo-American Center · US

Funding

The Oncofertility Consortium: Fertility Preservation for WomanUL1RR024926 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2007 to 2007
$692k
The Oncogenic Significance of Cyclin Overexpression and Smad 3 Tumor SuppressionK22CA138776 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JERUSS, JACQUELINE SARA · 2010 to 2012
$561k
NCI NIH HHS K22 CA138776NCRR NIH HHS UL1 RR024926PHS HHS UL1 RRR024926
6 · The paper itself

Abstract

objectiveTo examine the impact of hormones used for controlled ovarian hyperstimulation (COH) on normal and malignant breast cell growth and proliferation.

designIn vitro study of cultured normal and malignant breast cell lines.

settingAcademic medical center. PATIENT(S): None. INTERVENTION(S): Normal and malignant breast cell lines cultured in two- and three-dimensional (2D and 3D) systems and treated with follicle-stimulating hormone (FSH), luteinizing hormone (LH), or FSH with LH or human chorionic gonadotropin (hCG). MAIN OUTCOME MEASURE(S): Effects of treatment on cell proliferation in 2D culture using the MTS assay and on colony growth in 3D culture. RESULT(S): Compared with untreated cells, normal MCF-10A cells showed a decrease in proliferation and colony size when exposed to a combination of FSH and hCG. The HCC 1937 cells treated with FSH and LH also showed a decrease in colony growth but no change in proliferation. None of the treatments had an effect on the proliferation or colony size of the MCF-7 cells. CONCLUSION(S): Follicle-stimulating hormone, LH, and hCG do not appear to cause an increase in cell proliferation or colony growth in either normal or malignant mammary epithelial cell lines. The potential risk for mammary cell transformation associated with these agents may be related to indirect endocrine effects on breast cell physiology.

Indexed as

Ovulation InductionBreast NeoplasmsCell Culture TechniquesCell Line, TumorCell ProliferationChorionic GonadotropinDrug Therapy, CombinationEpithelial CellsFemaleFertility Agents, FemaleFollicle Stimulating HormoneHumansLuteinizing HormoneMammary Glands, HumanTime FactorsChorionic GonadotropinFertility Agents, FemaleFollicle Stimulating HormoneLuteinizing Hormone

Identifiers

PMID22188984
PMCPMC3269531
OpenAlexW2007949624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.